Jeff E. Glasgow
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Supramolecular Self-Assembly in Materials
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
Papers in
-
- Nanoparticle-Based Drug Delivery 4
-
- SARS-CoV-2 and COVID-19 Research 3
- SARS-CoV-2 detection and testing 2
- Co-authors
- Danielle Tullman‐Ercek (4 shared papers)Matthew B. Francis (4 shared papers)Jennifer R. Cochran (3 shared papers)Marc Salit (2 shared papers)James A. Wells (6 shared papers)Michael P. Coyle (1 shared paper)Irene Lui (3 shared papers)Xin X. Zhou (3 shared papers)
- Journals
- Journal of the American Chemical Society (2 papers)Cell chemical biology (2 papers)Nano Letters (1 paper)Nucleic Acids Research (1 paper)Science Advances (1 paper)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Jeff E. Glasgow
19 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 72
- Biomaterials 200
- Infectious Diseases 294
- Molecular Biology 430
- Ecology 83
- Biotechnology 25
Countries citing papers authored by Jeff E. Glasgow
This map shows the geographic impact of Jeff E. Glasgow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff E. Glasgow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff E. Glasgow more than expected).
Fields of papers citing papers by Jeff E. Glasgow
This network shows the impact of papers produced by Jeff E. Glasgow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff E. Glasgow. The network helps show where Jeff E. Glasgow may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeff E. Glasgow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 197 | |
| 2 | 2017 | 150 | |
| 3 | 2021 | 122 | |
| 4 | 2012 | 121 | |
| 5 | 2013 | 89 | |
| 6 | 2016 | 79 | |
| 7 | 2020 | 70 | |
| 8 | 2014 | 68 | |
| 9 | 2015 | 58 | |
| 10 | 2020 | 40 | |
| 11 | 2016 | 37 | |
| 12 | 2022 | 34 | |
| 13 | 2017 | 27 | |
| 14 | 2018 | 12 | |
| 15 | 2022 | 9 | |
| 16 | 2025 | 9 | |
| 17 | 2023 | 4 | |
| 18 | 2024 | 3 | |
| 19 | Mutagenesis of the Cyclic-Amp Receptor Protein of Escherichia-Coli - Targeting Position-83, Position-127 and Position-128 of the Cyclic-Nucleotide Binding Pocket | 1994 | 1 |
About Jeff E. Glasgow
Jeff E. Glasgow is a scholar working on Biomaterials, Infectious Diseases, Ecology, Molecular Biology and Immunology, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include Bacteriophages and microbial interactions (4 papers), Nanoparticle-Based Drug Delivery (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), SARS-CoV-2 detection and testing (2 papers), Enzyme Catalysis and Immobilization (2 papers), Biochemical and Structural Characterization (2 papers), Receptor Mechanisms and Signaling (1 paper) and RNA and protein synthesis mechanisms (1 paper). The work is most often cited by research in Biomaterials (200 citations), Infectious Diseases (294 citations), Molecular Biology (430 citations), Ecology (83 citations) and Biotechnology (25 citations). Jeff E. Glasgow has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Danielle Tullman‐Ercek, Matthew B. Francis, Jennifer R. Cochran, Marc Salit, James A. Wells, Michael P. Coyle, Irene Lui, Xin X. Zhou, Kevin Leung and Shion An Lim. Their work appears in journals such as Journal of the American Chemical Society, Cell chemical biology, Nano Letters, Nucleic Acids Research and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.